Pfizer files for Patent on Known Substance

This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether unpublished patent applications can render a substance as “known” and critiques the merging of novelty and subject matter analysis.

Read more about Pfizer files for Patent on Known Substance

PIL, IPO and Statement of Working of Patents

This post explores the statutory requirements for the statement of working of patents in India, assessing the legal provisions and practical challenges faced by the patent office. It provides an analytical perspective on compliance, resource implications, and public interest concerns within the Indian patent framework.

Read more about PIL, IPO and Statement of Working of Patents

Intellectual Property (IP) in India: A Decade of Progress Part 11

This post presents a statistical overview of pharmaceutical patents in India over the past decade, focusing on trends and key contributors. It objectively discusses the impact of legal changes and regulatory measures on patent filings in the pharmaceutical sector.

Read more about Intellectual Property (IP) in India: A Decade of Progress Part 11